Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Sometimes, markets don’t need breathless buzzwords to get excited. Sometimes, “marginally encouraging” will do. Ask Pfizer shareholders.
It’s part of the EU’s goal to build its own spacefaring infrastructure, reducing its dependence on US private companies.
Besides being your one-stop-retail-shop for everything, Walmart would like to be your virtual banker, too.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
After making itself an integral part of the supply chain for generative AI, Nvidia is eyeing other futuristic tech bets.
A day after antitrust enforcers successfully blocked Albertsons’ planned sale to Kroger, the former filed a lawsuit against the latter.
Amazon touts itself as the everything store, and now there’s one more market it’s absorbing into its everythingness.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
A federal appeals court upheld the “TikTok Ban” that would force China-based ByteDance to sell its app next month or face exile from the US.
The global oil cartel announced it would be extending its ongoing production cuts through the first few months of next year.
So far this year, hurricanes, thunderstorms, and floods have cost the insurance industry a collective $135 billion in losses.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.